[1] Koumbi L.Dietary factors can protect against liver cancer development. World J Hepatol,2017,9(3):119-121. [2] Niessen C,Igl J,Pregler B,et al.Factors associated with short-term local recurrence of liver cancer after percutaneous ablation using irreversible electroporation:A prospective single-center study. J Vasc Int Radiol,2015,26(5):694-702. [3] Zhu P,Yuan S,Liao Y,et al.High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma. World J Gastroenterol,2015,21(23):7254-7263. [4] 曾信豪,林泽锋,张红,等. EpCAM阳性的不成熟胆道上皮细胞促进胆道闭锁肝纤维化的研究. 中华小儿外科杂志,2016,37(3):201-205. [5] Ji J,Zheng X,Forgues M,et al.Identification of microRNAs specific for epithelial cell adhesion molecule-positive tumor cells in hepatocellular carcinoma. Hepatology,2015,62(3):829-840. [6] Guan D,Shi J,Zhang Y,et al.Sorafenib enriches epithelial cell adhesion molecule-positive tumor initiating cells and exacerbates a subtype of hepatocellular carcinoma through TSC2-AKT cascade. Hepatology,2015,62(6):1791-1803. [7] Chen VL,Le AK,Podlaha O,et al.Soluble intercellular adhesion molecule-1 is associated with hepatocellular carcinoma risk:multiplex analysis of serum markers. Sci Rep,2017,7(1):90-92. [8] Wang C,Yang L,Liang Z,et al.Long-term survival and prognostic factors of pulmonary metastasectomy in liver cancer:A systematic review and Meta-analysis. World J Surg,2018,26(05):90-93. [9] Smith JW,Kroker-Lobos MF,Lazo M,et al.Aflatoxin and viral hepatitis exposures in Guatemala:Molecular biomarkers reveal a unique profile of risk factors in a region of high liver cancer incidence. Plos One,2017,12(12):255-257. [10] 刘东明,张伟,周洪渊,等. 混合型肝癌患者的预后因素分析. 中华肝胆外科杂志,2017,23(4):272-274. [11] Khosla R,Rastogi A,Ramakrishna G,et al.EpCAM+ liver cancer stem-like cells exhibiting autocrine Wnt signaling potentially originate in cirrhotic patients. Stem Cell Translat Med,2017,6(3):807-818. [12] Nio K,Yamashita T,Okada H,et al.Defeating EpCAM+ liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma. J Hepatol,2015,63(5):1164-1172. [13] Rojas A,Zhang P,Wang Y,et al.A positive TGF-β/c-KIT feedback loop drives tumor progression in advanced primary liver cancer. Neoplasia,2016,18(6):371-386. [14] Huang H,Hu M,Li P,et al.Mir-152 inhibits cell proliferation and colony formation of CD133+ liver cancer stem cells by targeting kit. Tumor Biol,2015,36(2):921-928. [15] Banka VK,Moon S,Jeong JM,et al.Development of 4-hexadecyl-4,7-diaza-1,10-decanedithiol (HDD) kit for the preparation of the liver cancer therapeutic agent Re-188-HDD/lipiodol. Nucl Med Biol,2015,42(3):317-322. [16] Wang J,Tang X,Weng W,et al.The membrane protein melanoma cell adhesion molecule (MCAM) is a novel tumor marker that stimulates tumorigenesis in hepatocellular carcinoma. Oncogene,2015,34(47):5781-5795. [17] Babaei M,Abnous K,Taghdisi SM,et al.Synthesis of theranostic epithelial cell adhesion molecule targeted mesoporous silica nanoparticle with gold gatekeeper for hepatocellular carcinoma. Nanomedicine,2017,12(11):1261-1279. [18] Li Y,Farmer RW,Yang Y,et al.Epithelial cell adhesion molecule in human hepatocellular carcinoma cell lines:a target of chemoresistence. BMC Cancer,2016,16(1):90-93. [19] Tanaka Y,Aishima S,Kohashi K,et al.Spalt-like transcription factor 4 immunopositivity is associated with epithelial cell adhesion molecule expression in combined hepatocellular carcinoma and cholangiocarcinoma. Histopathology,2016,68(5):693-701. |